An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1U01CA232486-01
Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions
National Institutes of Health
Grant: 5U01CA243072-05
Towards rational design of combination therapeutic targets
National Institutes of Health
Grant: 5R01CA216981-05
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia
National Institutes of Health
Grant: 3P30CA013696-21S1
CANCER CENTER CORE SUPPORT GRANT
National Institutes of Health
Grant: 3U01CA232563-01S2
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy
National Institutes of Health
Grant: 5R35CA210065-05
Molecular pathways and targeted therapies in human leukemia
Fields of Study
Keywords
Sustainable Development Goals